株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

糖尿病ケアデバイス市場:製品 - 世界の機会分析および業界予測

Diabetes Care Devices Market by Product (Blood Glucose Monitoring Devices and Insulin Delivery Devices) - Global Opportunity Analysis and Industry Forecasts, 2017-2023

発行 Allied Market Research 商品コード 563355
出版日 ページ情報 英文 120 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.43円で換算しております。
Back to Top
糖尿病ケアデバイス市場:製品 - 世界の機会分析および業界予測 Diabetes Care Devices Market by Product (Blood Glucose Monitoring Devices and Insulin Delivery Devices) - Global Opportunity Analysis and Industry Forecasts, 2017-2023
出版日: 2017年08月01日 ページ情報: 英文 120 Pages
概要

当レポートでは、世界の糖尿病ケアデバイス市場について調査し、市場の製品別、地域別動向、および市場に参入する主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
  • 市場シェア分析
  • 市場動向
    • 促進因子
    • 阻害因子
    • 機会
    • 影響分析
  • 治験

第4章 製品別市場

  • 概要
  • 血糖モニタリングデバイス
    • 自己モニタリング血糖メーター
    • ランセット
    • 継続的血糖モニター
  • インスリンデリバリーデバイス
    • インスリンシリンジ
    • インスリンペン
    • インスリンポンプ
    • インスリンジェットインジェクター

第5章 地域別市場

  • 概要
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ

第6章 企業プロファイル

目次
Product Code: LI 172842

The global diabetes care devices market was valued at $6,867 million in 2016, and is growing at a CAGR of 5.8% from 2017 to 2023 to reach $10,208 million by 2023. Diabetes care devices are used to check the blood glucose or the insulin level in a patient's body.

The major factor that contributes to the growth of the diabetes care devices market include the increase in incidence rate of diabetes caused by rapid urbanization and sedentary lifestyle. Moreover, technological advancements in the field of diabetes devices, rise in obese population, consumption of junk food, and surge in need for faster and safer diagnosis and treatment of diabetes further boosts the market growth. However, blood glucose monitoring devices do not measure the exact level of glucose in blood and give a range in which the blood glucose level of a patient may lie. In addition, adverse effects associated with some of the diabetes care devices also hinder the market growth. In addition, rise in awareness about diabetes monitoring devices, and untapped market opportunities in the developing regions are expected to provide numerous opportunities for the market growth.

Diabetes care devices market is segmented on the basis of type and region. Based on type, the market is bifurcated into blood glucose monitoring devices and insulin delivery devices. Blood glucose monitoring devices are categorized into testing strips, self-monitoring blood glucose meters, lancets, and continuous glucose monitoring devices. Insulin delivery devices segment is further divided into insulin syringes, insulin pens, insulin pumps, and insulin jet injectors. By geography, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides information about the current and upcoming trends in the market from 2016 to 2023, which helps to determine the prevailing opportunities.
  • Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
  • Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale are provided.
  • Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which help understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

BY PRODUCT

  • Blood Glucose Monitoring Devices
  • Testing Strips
  • Self-monitoring Blood Glucose Meters
  • Lancets
  • Continuous Blood Glucose Monitoring Devices
  • Insulin Delivery Devices
  • Insulin Syringes
  • Insulin Pens
  • Insulin Pumps
  • Insulin Jet Injectors

BY REGION

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
  • LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Ascensia Diabetes Care Holdings AG (formerly diabetes case business of Bayer AG)
  • Becton, Dickinson and Company
  • Dexcom, Inc.
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Medtronic plc
  • Novo Nordisk A/S
  • Terumo Corporation
  • LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
  • Arkray, Inc.
  • Echo Therapeutics, Inc.
  • Glysens Incorporated
  • Insulet Corporation
  • Sanofi
  • Ypsomed AG

Table of Contents

CHAPTER 1 INTRODUCTION

  • 1.1. REPORT DESCRIPTION
  • 1.2. KEY BENEFITS FOR STAKEHOLDERS
  • 1.3. KEY MARKET SEGMENTS
  • 1.4. RESEARCH METHODOLOGY
    • 1.4.1. Secondary research
    • 1.4.2. Primary research
    • 1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

  • 2.1. KEY FINDINGS OF THE STUDY
  • 2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

  • 3.1. MARKET DEFINITION AND SCOPE
  • 3.2. KEY FINDINGS
    • 3.2.1. Top investment pockets
    • 3.2.2. Top winning strategies
      • 3.2.2.1. Competitive intelligence of companies and their strategies
  • 3.3. MARKET SHARE ANALYSIS, 2016
  • 3.4. MARKET DYNAMICS
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
    • 3.4.4. Impact analysis
  • 3.5. CLINICAL TRIALS

CHAPTER 4 GLOBAL DIABETES CARE DEVICES MARKET, BY PRODUCT

  • 4.1. OVERVIEW
    • 4.1.1. Market size and forecast
  • 4.2. BLOOD GLUCOSE MONITORING DEVICES
    • 4.2.1. Key market trends
    • 4.2.2. Growth factors and opportunities
    • 4.2.3. Market size and forecast
    • 4.2.4. Testing Strips
      • 4.2.4.1. Market size and forecast
    • 4.2.5. Self-monitoring Blood Glucose Meters
      • 4.2.5.1. Market size and forecast
    • 4.2.6. Lancets
      • 4.2.6.1. Market size and forecast
    • 4.2.7. Continuous Glucose Monitors
      • 4.2.7.1. Market size and forecast
  • 4.3. INSULIN DELIVERY DEVICES
    • 4.3.1. Key market trends
    • 4.3.2. Growth factors and opportunities
    • 4.3.3. Market size and forecast
    • 4.3.4. Insulin Syringes
      • 4.3.4.1. Market size and forecast
    • 4.3.5. Insulin Pens
      • 4.3.5.1. Market size and forecast
    • 4.3.6. Insulin Pumps
      • 4.3.6.1. Market size and forecast
    • 4.3.7. Insulin Jet Injectors
      • 4.3.7.1. Market size and forecast

CHAPTER 5 DIABETES CARE DEVICES MARKET, BY REGION

  • 5.1. OVERVIEW
    • 5.1.1. Market size and forecast
  • 5.2. NORTH AMERICA
    • 5.2.1. Key market trends
    • 5.2.2. Key growth factors and opportunities
    • 5.2.3. Market size and forecast
    • 5.2.4. U.S.
    • 5.2.5. Canada
    • 5.2.6. Mexico
  • 5.3. EUROPE
    • 5.3.1. Key market trends
    • 5.3.2. Key growth factors and opportunities
    • 5.3.3. Market size and forecast
    • 5.3.4. Germany
    • 5.3.5. France
    • 5.3.6. UK
    • 5.3.7. Italy
    • 5.3.8. Spain
    • 5.3.9. Rest of Europe
  • 5.4. ASIA-PACIFIC
    • 5.4.1. Key market trends
    • 5.4.2. Key growth factors and opportunities
    • 5.4.3. Market size and forecast
    • 5.4.4. Japan
    • 5.4.5. China
    • 5.4.6. India
    • 5.4.7. Australia
    • 5.4.8. South Korea
    • 5.4.9. Rest of Asia-Pacific
  • 5.5. LAMEA
    • 5.5.1. Key market trends
    • 5.5.2. Key growth factors and opportunities
    • 5.5.3. Market size and forecast
    • 5.5.4. Brazil
    • 5.5.5. South Africa
    • 5.5.6. Saudi Arabia
    • 5.5.7. Rest of LAMEA

CHAPTER 6 COMPANY PROFILES

  • 6.1. ABBOTT LABORATORIES
    • 6.1.1. Company overview
    • 6.1.2. Operating business segments
    • 6.1.3. Business performance
    • 6.1.4. Key strategic moves and developments
  • 6.2. ACON LABORATORIES, INC.
    • 6.2.1. Company overview
    • 6.2.2. Operating business segments
    • 6.2.3. Business performance
    • 6.2.4. Key strategic moves and developments
  • 6.3. ASCENSIA DIABETES CARE HOLDINGS AG
    • 6.3.1. Company overview
    • 6.3.2. Operating business segments
    • 6.3.3. Key strategic moves and developments
  • 6.4. BECTON, DICKINSON AND COMPANY
    • 6.4.1. Company overview
    • 6.4.2. Operating business segments
    • 6.4.3. Business performance
    • 6.4.4. Key strategic moves and developments
  • 6.5. DEXCOM, INC.
    • 6.5.1. Company overview
    • 6.5.2. Operating business segments
    • 6.5.3. Business performance
    • 6.5.4. Key strategic moves and developments
  • 6.6. F. HOFFMANN-LA ROCHE LTD.
    • 6.6.1. Company overview
    • 6.6.2. Operating business segments
    • 6.6.3. Business performance
    • 6.6.4. Key strategic moves and developments
  • 6.7. JOHNSON & JOHNSON
    • 6.7.1. Company overview
    • 6.7.2. Operating business segments
    • 6.7.3. Business performance
    • 6.7.4. Key strategic moves and developments
  • 6.8. MEDTRONIC PLC
    • 6.8.1. Company overview
    • 6.8.2. Operating business segments
    • 6.8.3. Business performance
    • 6.8.4. Key strategic moves and developments
  • 6.9. NOVO NORDISK A/S
    • 6.9.1. Company overview
    • 6.9.2. Operating business segments
    • 6.9.3. Business performance
    • 6.9.4. Key strategic moves and developments
  • 6.10. TERUMO CORPORATION
    • 6.10.1. Company overview
    • 6.10.2. Operating business segments
    • 6.10.3. Business performance
    • 6.10.4. Key strategic moves and developments
Back to Top